EUROPEAN ASSOCIATION OF HAEMOPHILIA AND ALLIED D..

13th Annual Congress of EAHAD

 

5-7 February 2020 Hague
Close
N. Poster
Poster title
Applicant name
Status
  P-001 ONE STAGE AND CHROMOGENIC FVIII ASSAY RESULTS AT TROUGH LEVELS: A UK NATIONAL EXTERNAL QUALITY ASSESSMENT SCHEME FOR BLOOD COAGULATION (UK NEQAS BC) EXERCISE. Anna Lowe Received Received
  P-002 HUMAN CHROMOGENIC FVIII ASSAY RESULTS ARE DEPENDENT ON SAMPLE DILUTION WHEN EMICIZUMAB IS PRESENT: ADDITIONAL ANALYSIS FROM THE FIRST UK NATIONAL EXTERNAL QUALITY ASSESSMENT SCHEME FOR BLOOD COAGULATION (UK NEQAS BC) FVIII INHIBITOR/EMICIZIMAB SUPPLEMENTARY EXERCISE. Anna Lowe Received Received
  P-003 LABORATORY MEASUREMENT OF EMICIZUMAB FIRST REAL-LIFE EXPERIENCE FROM KAROLINSKA UNIVERSITY LABORATORY Anna Sjstrm Received Received
  P-006 DELAYS IN THE DIAGNOSIS OF ACQUIRED HAEMOPHILIA IN THREE MEN DUE TO PROLONGED APTTS AND SEVERE BRUISING BEING INITIALLY ATTRIBUTED TO ORAL ANTICOAGULANT THERAPY Charlene Neill Received Received
  P-007 METHODOLOGICAL VALIDATION OF THE MEASUREMENT OF ULTRA-LOW LEVELS OF FACTOR VIII ACTIVITY BY CHRONOMETRIC APTTBASED ASSAY. Clémentine WAHL Received Received
  P-018 GENETIC DIAGNOSIS AND MOLECULAR EPIDEMIOLOGY DESCRIPTION OF A COHORT OF 109 HEMOPHILIC CUBANS. Nina Borràs Received Received
  P-021 CHARACTERIZATION OF A NEW CHROMOGENIC FACTOR VIII ASSAY CONTAINING HUMAN FIXA AND BOVINE FX. Pia Bryngelhed Received Received
  P-024 EMICIZUMAB ASSOCIATES WITH ACTIVATED FXI AND INTRINSIC PATHWAY OF COAGULATION CAPTURED BY THROMBOELASTOGRAPHY AND CORN TRYPSIN INHIBITOR Timea Szanto Received Received
  P-044 ASSESSING A POPULATION PHARMACOKINETIC MODEL OF A PLASMA-DERIVED, VON WILLEBRAND FACTOR-CONTAINING FVIII CONCENTRATE FOR BAYESIAN FORECASTING IN LOW DOSE SCENARIOS Dr. Edginton Received Received
  P-045 SUCCESSFUL LASER REFRACTIVE EYE SURGERY DURING TREATMENT WITH CONCIZUMAB IN A PATIENT WITH SEVERE HAEMOPHILIA A WITH AN INHIBITOR Alison Delaney Received Received
  P-057 RESULTS OF A PHASE 1 REPEAT DOSE OF BIVV001 A NEW CLASS OF FACTOR VIII REPLACEMENT THERAPY Liza ORourke Received Received
  P-059 ASSESSING THE MINIMUM AND IDEAL FACTOR LEVELS FOR PARTICIPATION IN PHYSICAL ACTIVITIES BY PEOPLE WITH HAEMOPHILIA: AN EXPERT ELICITATION STUDY Antony Martin Received Received
  P-061 REAL LIFE, LONG-TIME DOCUMENTATION ON THE USE OF A SINGLE PLASMATIC FACTOR IX CONCENTRATE Artur Bauhofer Received Received
  P-076 COMPARATIVE EFFECTIVENESS AND SAFETY, AND HEALTH-RELATED QUALITY OF LIFE OF HAEMOPHILIA A TREATMENTS: A SYSTEMATIC REVIEW Charles Hawes Received Received
  P-077 COMPARING THE SENSITIVITY OF PATIENT-LEVEL DISCRETE EVENT SIMULATION AND COHORT HEALTH-STATE TRANSITION MODELLING FRAMEWORKS IN THE ADVENT OF NOVEL THERAPIES FOR PEOPLE WITH SEVERE HAEMOPHILIA A. charles hawes Received Received
  P-080 TREATMENT PATTERNS OF FVIII PRODUCTS FOR HAEMOPHILIA A IN SWEDEN ANALYSIS OF NATIONAL REAL WORLD DATA Christian Gerdeskold Received Received
  P-087 SUCCESSFUL EXPERIENCE EMICIZUIMAB: ZERO T.A.S Mauricio Jaramillo Received Received
  P-097 DEVELOPMENT AND TESTING OF THE ONLINE PROBE SURVEY AND THE MYPROBE APP AND INTEGRATION WITH THE CANADIAN BLEEDING DISORDER REGISTRY Federico Germini Received Received
  P-103 TIME TO NEGATIVE INHIBITOR TITRE IN SEVERE HAEMOPHILIA A PATIENTS WITH LOW TITRE INHIBITORS IS SIMILAR REGARDLESS OF ITI TREATMENT; DATA FROM PEDNET COHORT Marloes de Kovel Received Received
  P-119 CLINICAL MANAGEMENT OF WOMEN WITH BLEEDING DISORDERS: RESULTS OF A SURVEY AMONG EUROPEAN HEMOPHILIA TREATMENT CENTERS Karin van Galen Received Received
  P-125 QUALITY OF LIFE IN HAEMOPHILIC PATIENTS FROM A NORTHERN REGION OF SPAIN. Angel Bernardo Gutiérrez Received Received
  P-126 EVALUATION OF PAIN AND FUNCTIONAL CAPACITY IN HAEMOPHILIC PATIENTS IN A NORTHERN REGION OF SPAIN. LAURA ESCALADA GONZALEZ Received Received
  P-139 BRAVE BLEEDING RATES IN HEMOPHILIA A: REAL-WORLD EVIDENCES IN BRAZIL Albertina Rosa Borges Received Received
  P-145 HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MILD HAEMOPHILIA: A PROSPECTIVE OBSERVATIONAL STUDY Mariasanta Napolitano Received Received
  P-147 THE WORLD BLEEDING DISORDERS REGISTRY CELEBRATES 2 YEARS Mayss Naccache Received Received
  P-152 JOINT STATUS AND HEALTH RELATED QUALITY OF LIFE IN ADULTS WITH HEMOPHILIA IN MOROCCO. Najia Belhaj Received Received
  P-155 IMPACT OF THE AVAILABILITY OF EXTENDED HALF-LIFE FACTOR VIII ON THE TREATMENT MODALITIES OF PATIENTS WITH SEVERE HAEMOPHILIA A IN THE NORTHWEST AREA OF FRANCE (MOTHIF II STUDY) Nicolas DRILLAUD Received Received
  P-175 POWER: AN INNOVATIVE APPROACH FOR CLINICAL STUDY DESIGN BASED ON STRUCTURED CO-CREATION BETWEEN INDUSTRY, PHYSICIANS, ACADEMIA AND PATIENTS ASSOCIATIONS. Rosaria Tempre Received Received
  P-177 INTERNATIONAL STANDARD SET OF HEALTH OUTCOMES THAT MATTER FOR PEOPLE LIVING WITH HEMOPHILIA Samantha Gouw Received Received
  P-179 COLLABORATION OF CARE TO ENABLE ACCESS TO NEW MEDICINES FOR PATIENTS NOT REGISTERED WITH A COMPREHENSIVE CARE CENTRE Sarah Johns Received Received
  P-216 QUALITY OF LIFE IN HEMOPHILIA AND VON WILLEBRAND DISEASE PATIENTS IN BOSNIA AND HERZEGOVINA Emina Suljovic-Hadzimesic Received Received
  P-244 CORRECTING FVII DEFICIENCY USING COAGULATION FACTORS PRODUCED IN VIVO BY ENCAPSULATED ENGINEERED ALLOGENEIC CELLS Jelena Garafalo Received Received
  P-273 DOLPHIN: DEVELOPMENT OF A HAEMOPHILIA PHYSIOTHERAPY INTERVENTION FOR OPTIMUM MUSCULOSKELETAL HEALTH INTERIM RESULTS OF A RANDOMISED CONTROLLED TRIAL David Stephensen Received Received
  P-274 IDENTIFYING PERFORMANCE-BASED OUTCOME MEASURES OF PHYSICAL FUNCTION IN PEOPLE WITH HAEMOPHILIA (IPOP) David Stephensen Received Received
  P-283 HEMFITBIT - AN OBSERVATIONAL STUDY OF PHYSICAL ACTIVITY IN TEENAGERS AND YOUNG ADULTS WITH HAEMOPHILIA A Ruth Elise Matlary Received Received
  P-295 HEMOVE - THE HEMOPHILIA LIFESTYLE COACH - AN EXTRAORDINARY PILOT PROJECT Ann Devos Received Received
  P-298 HAEMOPHILIA CARRIERS EXPERIENCE STUDY: LIFE CHOICES, PSYCHOSOCIAL NEEDS AND PARENTING (CARES) Sarah Mangles Received Received
  P-300 SOCIAL SUPPORT AND RESILIENCE IN PATIENTS SUFFERING WITH SEVERE HAEMOPHILIA AND INHIBITORS FIRST ANALYSIS OF THE PILOT PROJECT Kate&345;ina Ratajová Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
07:41
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

13th Annual Congress of EAHAD

 

5-7 February 2020 Hague
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 05/02/2020 TO 05/02/2020
Poster
Gallery
Upload
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
                  




PosterSessionOnline
Logo Draft
 
Logo Cert